New Hope for PBC Patients: Emerging Therapies and Targets
Are you or someone close to you struggling with an untreatable liver condition? This might just be the breakthrough you’ve been waiting for. Primary Biliary Cholangitis (PBC) is a slow but stubborn liver disease that mostly affects middle-aged women. For years, patients had very limited options, mainly just one medicine. But now, there’s a shift in the air. Researchers and doctors are finally seeing light at the end of the tunnel, thanks to new treatment approaches that are changing lives and rewriting the future of liver care. Let’s break it down and explore what’s coming up in the world of PBC therapy. What is the new treatment approach for PBC? Traditionally, treatment for PBC has focused on slowing the disease progression and managing symptoms, such as fatigue, itchy skin, or joint pain. Udiliv 300mg Tablet uses are well-known in such cases, as it contains Ursodeoxycholic acid (UDCA), which has been the standard medication for decades. However, up to 40% of patients don’t respond...